Asthma Clinical Trial
Official title:
Can Education for South Asians With Asthma and Their Clinicians Reduce Unscheduled Care? A Cluster Randomised Trial
People from ethnic minority groups suffer worse ill-health from asthma than those from
majority groups. No studies have reduced emergency care for people from minority groups. We
have developed an education programme to address barriers to improved care for south Asian
people with asthma. The study is set in Tower Hamlets and Newham - the UK's most deprived
and ethnically diverse boroughs. We will invite all the local GP practices to take part, and
using a computer programme, randomised them (like tossing a coin) into two groups - a group
receiving usual care and a group receiving our educational programme. This comprises:
- Education for specialist nurse and GPs and practice nurses, using our adaptation of an
American education course, designed to improve shared-decision making, goal-setting and
patient-clinician partnership.
- Lay-led 'expert-patient' education in small groups for patients, using an adaptation of
another American course.
- Improved follow-up in primary care through appointment-booking by the specialist
nurse.We will invite south Asians aged 3-65 years with asthma after A&E attendance or
hospital admission to take part. Those registered with practices receiving the
educational programme will see the trial specialist nurse in a nurse-run clinic, where
the nurse:
1. provides self-management advice and a treatment plan,
2. makes a follow-up appointment in primary care
3. makes an appointment for lay-led 'expert-patient' sessions.Patients registered
with 'usual care' practices receive usual care.
We will decide if our education programme works by comparing the number of emergency visits
to GPs and hospital between the two groups.
Health inequalities between ethnic minority and majority groups exist for all chronic
diseases and are a government priority for action. For asthma, poorer outcomes for people
from minority groups are a universal finding. No randomised trials have reduced emergency
asthma care for ethnic minority groups.
We have developed an intervention to address barriers to improved asthma care for south
Asian people with asthma. This cluster randomised controlled trial tests whether education
for south Asians with asthma and their clinicians can reduce unscheduled care. The trial is
set in Tower Hamlets and Newham - boroughs with UK's 1st and 3rd highest ethnic minority
populations.
We will invite all 94 general practices in these boroughs to take part. Practices will be
randomised with stratification to intervention and control groups. The intervention
comprises:
- Education for intervention specialist nurse and GPs and practice nurses from
intervention practices, using our adaptation of Clarke's self-regulation education
programme, designed to improve shared-decision making, goal-setting and
patient-clinician partnership.
- Lay-led 'expert-patient' education in small groups for patients, using an adaptation of
Lorig's chronic disease self-management programme.
- Improved follow-up in primary care through appointment-booking by the specialist nurse.
We will recruit south Asians aged 3-65 years with asthma after A&E attendance or hospital
admission. Participants registered with intervention practices will see the trial specialist
nurse in a nurse-run hospital clinic, where the nurse:
1. provides self-management advice and a treatment plan,
2. makes a follow-up appointment for the patient in primary care
3. makes an appointment for lay-led 'expert-patient' sessions.
Participants registered with control practices receive usual care. Primary outcomes are time
to first unscheduled contact with acute asthma, and proportion of participants with
unscheduled care, assessed from patient records 12 months after recruitment. Secondary
outcomes are generic (EQ5D) and disease specific quality of life (AQ20 and North of England
scales), prescribing and costs. The trial is powered to detect a 20% reduction in patients
attending with unscheduled care (80% power 5% significance). Outcomes will be gathered by
blinded researchers. Analysis will be carried out blind to allocation. Cost-effectiveness
will be assessed using standard incremental cost-effectiveness ratios.
;
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Health Services Research
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT04624425 -
Additional Effects of Segmental Breathing In Asthma
|
N/A | |
| Terminated |
NCT04410523 -
Study of Efficacy and Safety of CSJ117 in Patients With Severe Uncontrolled Asthma
|
Phase 2 | |
| Active, not recruiting |
NCT03927820 -
A Pharmacist-Led Intervention to Increase Inhaler Access and Reduce Hospital Readmissions (PILLAR)
|
N/A | |
| Completed |
NCT04617015 -
Defining and Treating Depression-related Asthma
|
Early Phase 1 | |
| Recruiting |
NCT03694158 -
Investigating Dupilumab's Effect in Asthma by Genotype
|
Phase 4 | |
| Terminated |
NCT04946318 -
Study of Safety of CSJ117 in Participants With Moderate to Severe Uncontrolled Asthma
|
Phase 2 | |
| Completed |
NCT04450108 -
Vivatmo Pro™ for Fractional Exhaled Nitric Oxide (FeNO) Monitoring in U.S. Asthmatic Patients
|
N/A | |
| Completed |
NCT03086460 -
A Dose Ranging Study With CHF 1531 in Subjects With Asthma (FLASH)
|
Phase 2 | |
| Completed |
NCT01160224 -
Oral GW766944 (Oral CCR3 Antagonist)
|
Phase 2 | |
| Completed |
NCT03186209 -
Efficacy and Safety Study of Benralizumab in Patients With Uncontrolled Asthma on Medium to High Dose Inhaled Corticosteroid Plus LABA (MIRACLE)
|
Phase 3 | |
| Completed |
NCT02502734 -
Effect of Inhaled Fluticasone Furoate on Short-term Growth in Paediatric Subjects With Asthma
|
Phase 3 | |
| Completed |
NCT01715844 -
L-Citrulline Supplementation Pilot Study for Overweight Late Onset Asthmatics
|
Phase 1 | |
| Terminated |
NCT04993443 -
First-In-Human Study to Evaluate the Safety, Tolerability, Immunogenicity, and Pharmacokinetics of LQ036
|
Phase 1 | |
| Completed |
NCT02787863 -
Clinical and Immunological Efficiency of Bacterial Vaccines at Adult Patients With Bronchopulmonary Pathology
|
Phase 4 | |
| Recruiting |
NCT06033833 -
Long-term Safety and Efficacy Evaluation of Subcutaneous Amlitelimab in Adult Participants With Moderate-to-severe Asthma Who Completed Treatment Period of Previous Amlitelimab Asthma Clinical Study
|
Phase 2 | |
| Completed |
NCT03257995 -
Pharmacodynamics, Safety, Tolerability, and Pharmacokinetics of Two Orally Inhaled Indacaterol Salts in Adult Subjects With Asthma.
|
Phase 2 | |
| Completed |
NCT02212483 -
Clinical Effectiveness and Economical Impact of Medical Indoor Environment Counselors Visiting Homes of Asthma Patients
|
N/A | |
| Recruiting |
NCT04872309 -
MUlti-nuclear MR Imaging Investigation of Respiratory Disease-associated CHanges in Lung Physiology
|
||
| Withdrawn |
NCT01468805 -
Childhood Asthma Reduction Study
|
N/A | |
| Recruiting |
NCT05145894 -
Differentiation of Asthma/COPD Exacerbation and Stable State Using Automated Lung Sound Analysis With LungPass Device
|